Krüppel-like factor 4 promotes c-Met amplification-mediated gefitinib resistance in non-small-cell lung cancer

Wei Feng1, Qianyi Xie1, Suo Liu1

  • 1Departments of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China.

Cancer Science
|April 7, 2018
PubMed

Insights

Krüppel-like factor 4 (KLF4) drives gefitinib resistance in non-small-cell lung cancer (NSCLC) with c-Met overexpression. Targeting KLF4 may overcome treatment resistance in these NSCLC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Gefitinib is a first-line treatment for advanced EGFR-mutated non-small-cell lung cancer (NSCLC).
  • Acquired resistance to gefitinib develops in many NSCLC patients within 9-14 months.
  • The mechanisms underlying gefitinib resistance, particularly in c-Met-overexpressing NSCLC, require further elucidation.

Purpose of the Study:

  • To investigate the role of Krüppel-like factor 4 (KLF4) in the development of gefitinib resistance in NSCLC.
  • To explore KLF4's interaction with c-Met signaling in gefitinib-resistant NSCLC cells.
  • To assess KLF4 as a potential therapeutic target for overcoming gefitinib resistance in NSCLC.

Main Methods:

  • Analysis of KLF4 expression in c-Met-overexpressing NSCLC cells and tissues.
  • In vitro studies involving KLF4 knockdown and overexpression in gefitinib-sensitive and resistant NSCLC cell lines.
  • Western blot analysis to examine protein expression and signaling pathway activation (c-Met/Akt/β-catenin).

Main Results:

  • KLF4 was overexpressed in c-Met-overexpressing NSCLC cells and tissues.
  • KLF4 knockdown reduced tumorigenicity and increased gefitinib sensitivity in c-Met-overexpressing resistant NSCLC cells.
  • KLF4 overexpression decreased gefitinib sensitivity in sensitive NSCLC cells.
  • KLF4 promoted gefitinib resistance by inhibiting apoptosis and activating the c-Met/Akt pathway.

Conclusions:

  • KLF4 plays a critical role in mediating gefitinib resistance in NSCLC with c-Met overexpression.
  • KLF4 influences gefitinib sensitivity by modulating apoptosis and the c-Met/Akt signaling pathway.
  • KLF4 represents a promising molecular target for the prevention and treatment of c-Met-overexpressing NSCLC.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.9K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.9K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.1K